Eculizumab in adolescents with PT-sensitive aHUS

  • Research type

    Research Study

  • Full title

    An open-label, multi-centre controlled clinical trial of Eculizumab in adolescent patients with plasma therapy-sensitive atypical Haemolytic-Uremic Syndrome (aHUS)

  • IRAS ID

    18414

  • Contact name

    Timothy H. J. Goodship

  • Contact email

    t.h.j.goodship@ncl.ac.uk

  • Sponsor organisation

    Alexion Pharmaceuticals, Inc

  • Eudract number

    2008-006955-28

  • ISRCTN Number

    N/A

  • Research summary

    Research Summary not published at request of researcher

  • REC name

    North East - Newcastle & North Tyneside 1 Research Ethics Committee

  • REC reference

    09/H0906/44

  • Date of REC Opinion

    28 May 2009

  • REC opinion

    Further Information Favourable Opinion